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Endothelial cells express very low density lipoprotein receptor (VLDLr). Beyond the function as
peripheral lipoprotein receptor, other roles of VLDLr in endothelial cells have not been completely
unraveled. In the present study, human umbilical vein endothelial cells were subjected to hypoxia,
and VLDLr expression, endoplasmic reticulum (ER) stress, and apoptosis were assessed. Hypoxia
triggered endothelial ER stress and apoptosis, and induced VLDLr expression. Silencing or stabiliza-
tion of HIF-1a reduced and enhanced VLDLr expression, respectively. HIF-1a affected vldlr promoter
activity by interacting with a hypoxia-responsive element (HRE). Knockdown or overexpression of
VLDLr alleviated and exacerbated hypoxia-induced ER stress and apoptosis, respectively. Thus,
hypoxia induces VLDLr expression through the interaction of HIF-1awith HRE at the vldlr promoter.
VLDLr then mediates ER stress and apoptosis.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The endoplasmic reticulum (ER) is a highly dynamic organelle
in eukaryotic cells, dysfunction of which results in ER stress and
disturbed protein folding processes, also termed as unfolded pro-
tein response (UPR). Commonly, a persistent UPR is correlated with
cellular malfunction. A large number of regulatory molecules
involved in UPR procedure and ER stress, such as glucose-regulated
protein 78 (GRP78, also termed Bip), a calcium dependent molecu-
lar chaperone riched in the ER lumen, protein kinase activated by
double-stranded RNA (PKR)-like ER kinase (PERK), a transmem-
brane protein which is associated with GRP78 in unstressed cells,
and CHOP, a proapoptotic protein, expression of which is strongly
promoted by PERK signaling when prosurvival exertion does not
overcome the sustained ER stress. As an important organelle, ER
controls cell survival and death in its own particular way. Both
intro- and extra-cellular factors inﬂuence ER homeostasis. There
is compelling evidence that disturbed ER functions play crucial
roles in a number of endothelial pathological processes and cardio-vascular disease, such as ischemic vascular disorder, neovasculari-
zation, and atherosclerosis [1–3].
The very low density lipoprotein (VLDL) receptor (VLDLr) is a
member of the low density lipoprotein (LDL) receptor family which
composed more than ten growing receptors. VLDLr is highly
expressed in fatty acid tissues. Tissues from the adipose layer, skel-
etal muscle, and heart express VLDLr. Additionally, VLDLr is pres-
ent in endothelial cells as well. Beyond the function of VLDLr as a
peripheral lipoprotein receptor, the possibilities of its biological
roles have been extended to the process of signal transduction,
angiogenesis, and tumor growth [4]. Recently, some study suggests
a regulatory role of VLDLr in the endothelial pathology. The activa-
tion of retinal vascular endothelial cells and promotion of angio-
genesis were mediated through VLDLr [5,6]. VLDLr modulated
ﬁbrin-dependent transendothelial migration of leukocytes [7].
VLDLr was used in microvascular endothelial cells to inhibit cell
division [8]. However, no further study was presented to clarify
the effects of VLDLr in the other endothelial pathological events,
such as cellular ER stress and apoptosis.
The aim of the current investigation was to detect the effect of
VLDLr on regulation of endothelial ER stress and apoptosis in the
condition of hypoxia. We provided evidence that hypoxia induced
VLDLr expression through a HIF-1a-dependent style, and the
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apoptosis.Fig. 1. Hypoxia triggers endothelial ER stress. HUVECs were treated with hypoxia
for the indicated time points. (A) The relative expression levels of GRP78 and CHOP
were detected by q-PT-PCR (n = 6, means ± SE). ⁄P < 0.05; ⁄⁄P < 0.01 vs. control cells.
(B) The protein levels of GRP78, CHOP, p-PERK, PERK, and b-actin were detected by
immunoblot analysis using indicated antibodies. A representative blot (top) was
shown (n = 4). Quantitative analysis of GRP78, CHOP, and p-PERK (bottom) was
expressed as fold increase above control group (n = 4, means ± SE). ⁄P < 0.05 vs.
control cells.2. Materials and methods
2.1. Antibodies and reagents
Anti-VLDL receptor (VLDLr) antibody was obtained form R&R
Systems, and anti-cleaved caspase-3, anti-cleaved caspase-8,
anti-cleaved caspase-9, anti-Bax, anti-Bcl-2, anti-b-actin and
HRP-conjugated secondary antibodies were from Cell Signaling
Technology. Anti-phospho-PERK, anti-PERK, anti-GRP78, anti-
CHOP, and anti-cleaved caspase-4 were purchased from Santa Cruz
Biotechnology. Dimethyloxalylglycine (DMOG) was obtained from
Cayman Chemical. All other chemicals were obtained from Sigma.
2.2. Cell culture and hypoxia incubation
Human umbilical vein endothelial cells (HUVECs) (Sciencell)
were cultured in endothelial cell medium (ECM) supplemented
with endothelial cell growth supplement (ECGS), 5% fetal bovine
serum (FBS), and penicillin/streptomycin (P/S) solution (Sciencell)
in an incubator with 37 C, 5% CO2. Cells of passage No. 4–6 were
grown until conﬂuence for experimental use. For experimental
hypoxia, cells were incubated with the serum-free medium and
placed in an airtight humidiﬁed chamber with 37 C, 5% CO2, and
95% N2. The corresponding normoxia control cells were cultured
in a humidiﬁed incubator with 37 C, 5% CO2, and 21% O2.
2.3. Transfection of siRNA and adenovirus
The VLDLr siRNA, HIF-1a siRNA, HIF-2a siRNA, and non-target-
ing siRNA used in our study were designed by Dharmacon. HUVECs
were transfected with siRNA (50 nmol/L) using DharmaFECT1 as
described previously [9]. The non-targeting siRNA was used as
transfection control for non-sequence-speciﬁc effects of the trans-
fected siRNAs. Recombinant adenoviruses expressing VLDLr or
control viruses were constructed using the Ad-Easy system. The
cultures were infected routinely at a multiplicity of infection of ﬁve
with an infection efﬁciency up to 80%.
2.4. Promoter constructs and luciferase reporter gene assay
The promoter fragments of vldlrwere PCR-ampliﬁed from geno-
mic DNA and cloned into a luciferase vector at the Kpn1 and Bgl II
site (pGL3; Promega, Madison, WI). The primers used for PCR
ampliﬁcation were as follows: 50-GAGGGTACCAGTCGAGCCCCT-30
(sense); 50-CTCAGATCTCATGCTGCCCGC-30 (antisense). The mutant
promoter pGL3vldlrHREmut was constructed by altering the puta-
tive hypoxia-responsive element (HRE) sequence CGTG (161 to
158 bp) to GATC (bold indicates changes). HUVECs were seeded
in 96-well plates and transfected with luciferase vector (100 ng,
pGL3 constructs), and Renilla vector (25 ng, pRLTK) using Lipofect-
amine 2000 (Invitrogen). Twenty-four hours later, cells were sub-
jected to hypoxia with or without SalA pretreatment and then
lysed. The ratios between ﬁreﬂy luciferase and Renilla luciferase
activity were determined with a dual-luciferase assay (Promega).
2.5. Quantitative realtime RT-PCR analysis
Total RNA was extracted from HUVECs with Trizol (Invitrogen).
Realtime PCR was performed with Bio-RAD iQ5 Multicolor Real-
Time PCR Detection System using SYBR Green as ﬂuorescent and
ROX (Takara) as reference dyes as described previously [9]. The
speciﬁc primers used were as follows: human VLDLr: 50-GTGGAAAATGTGATGGGGATG-30 (forward), 50-CCATTGTTGCACACGAAG
TC-30 (reverse); human GRP78: 50-GCCGCAGGCGCTGGAAAGAT-30
(forward), 50-GCCGATGAGTCGCTTGGCGT-30 (reverse); human
CHOP: 50-GGTGGCAGCGACAGAGCCAA-30 (forward), 50-CATGCGTT
GCTTGCCAGCCC-30 (reverse); human GAPDH: 50-GACCCCTTCA
TTGACCTC-30 (forward), 50-GCTAAGCAGTTGGTGGTG-30 (reverse).
2.6. Immunoblot analysis
Immunoblotting was performed according to the previous pro-
tocols [10]. Brieﬂy, total protein was extracted from HUVECs using
lysis buffer. Protein (50–60 lg) from each sample was separated
with SDS–PAGE, then transferred to nitrocellulose membranes,
and probed using primary antibodies and horseradish peroxidase
(HRP)-conjugated secondary antibodies. The chemiluminescence
signal was measured with a densitometry program (Gel-pro 4.5
Analyzer, Media Cybernetics). To calculate the protein signal, we
subtracted background, normalized the value to b-actin. To quan-
tify the phospho-speciﬁc protein, we normalized the value to the
Fig. 2. Hypoxia induces endothelial apoptosis. HUVECs were treated with hypoxia for the indicated time points. (A) The protein levels of cleaved caspase-3, cleaved caspase-
9, cleaved caspase-8, cleaved caspase-4, Bcl-2, Bax, and b-actin were detected by immunoblot analysis using indicated antibodies. A representative blot (top) was shown
(n = 4). Quantitative analysis of cleaved caspase-3, cleaved caspase-9, cleaved caspase-8, cleaved caspase-4, Bcl-2, and Bax (bottom) was expressed as fold increase above
control group (n = 4, means ± SE). ⁄P < 0.05 vs. control cells. (B) The cells were treated with hypoxia for 12 h and the apoptosis was measured by ﬂow cytometry analysis.
Representative photos of different groups were shown (top). The apoptotic cells were quantiﬁed (n = 4, means ± SE) (bottom). The values represent the mean percentages of
apoptotic cells in different groups. ⁄P < 0.05 vs. control cells.
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Fig. 3. Hypoxia induces expression of VLDLr and HIF-1a. HUVECs were treated with
hypoxia for the indicated time points. (A) The relative mRNA level of VLDLr was
detected by q-PT-PCR (n = 6, means ± SE). ⁄P < 0.05 vs. control cells. (B) The protein
levels of VLDLr, HIF-1a, and b-actin were detected by immunoblot analysis using
indicated antibodies. A representative blot (top) was shown (n = 4). Quantitative
analysis of VLDLr and HIF-1a (bottom) was expressed as fold increase above control
group (n = 4, means ± SE). ⁄P < 0.05 vs. control cells.
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were presented as a percentage of the control.
2.7. Flow cytometry assay
Cell apoptosis was analyzed by ﬂow cytometry using annexin
V-FITC/propidium iodide (PI) staining according to the manufac-
turer’s instructions (Invitrogen, USA). Brieﬂy, cells were rinsed
twice with ice-cold PBS and resuspended in 250 ll binding buffer
with a concentration of 2–5  105/ml. Then cells were added with
5 ll of annexin V-FITC stock solution and rinsed for 3 min at 4 C.
After that, cells were added with 10 ll PI (20 lg/ml) and incubated
10 min in the dark at room temperature. Cell apoptosis was ana-
lyzed using ﬂow cytometry (FACSCalibur, BD Biosciences, USA)
with Cell Quest software. Approximately 1  104 cells were ana-
lyzed with each sample.
2.8. Statistical analysis
Each experiment was performed at least in triplicate. All the
data were shown as means ± SE. Differences between groups were
assessed using Student’s t-test to determine statistical signiﬁcance.
In each case, P < 0.05 was considered signiﬁcant.
3. Results
3.1. Hypoxia triggers endothelial ER stress
Recent evidence indicated that hypoxia induced ER stress,
which was involved in the pathogenesis of cardiovascular disease
[3,11]. We thus examined the ER stress in endothelial cells. Exper-
imentally induced hypoxia in endothelial cells triggered elevated
mRNA level of GRP78 and CHOP (Fig. 1A). In agreement with the
mRNA levels, the GRP78 and CHOP protein levels were also pro-
moted by hypoxia (Fig. 1B). In addition, the hypoxia markedly pro-
moted phosphorylation of PERK (Fig. 1B). These results suggested a
signiﬁcant promotion of ER stress was elicited by hypoxia in endo-
thelial cells.
3.2. Hypoxia induces endothelial apoptosis
In concert with previous studies, our result indicated that
treatment of HUVECs with hypoxia signiﬁcantly induced the
expression of proapoptotic protein Bax, whereas the antiapoptotic
protein Bcl-2 was inhibited by hypoxia (Fig. 2A). Furthermore,
hypoxia remarkably increase the levels of cleaved caspase-3, cas-
pase-9, caspase-8, and caspase-4 (Fig. 2A). In addition, cellular
apoptosis was detected by ﬂow cytometry analysis. In the bottom
left quadrant located viable cells (annexin V-FITC-/PI-). Annexin
V-FITC +/PI-cells located in the bottom right quadrant represent
cellular status with early apoptosis. The result indicated that
hypoxia for 12 h induced a remarkable apoptosis of endothelial
cells (Fig. 2B).
3.3. Hypoxia induces VLDLr expression in endothelial cells
In physiological conditions, the endothelial cells express low
amounts of VLDLr. Previous evidences suggested that VLDLr med-
iated endothelial proliferation and angiogenesis. In our results,
quantitative RT-PCR and immunoblot analyses demonstrated that
VLDLr mRNA and protein levels increased signiﬁcantly in the hyp-
oxic endothelial cells (Fig. 3A and B). In addition, we also detected
high expression level of HIF-1a, which was markedly elicited by
hypoxia (Fig. 3B).3.4. Enhanced expression of VLDLr is dependent on HIF-1a
It seemed that induction of VLDLr expression was a common
responsiveness to hypoxic stress [12]. We therefore detected
whether HIF-1a was involved in the induction of VLDLr expression
under hypoxia condition. As expected, transfection of HUVECs with
HIF-1a siRNA hampered the hypoxia-induced upregulation of
VLDLr expression (Fig. 4A). Additionally, stabilization of HIF-1a
by dimethyloxalylglycine (DMOG) led to increased VLDLr expres-
sion (Fig. 4B). Further, Cobalt (II) Chloride (CoCl2), a chemical indu-
cer of HIF-1a, increased HIF-1a expression, as well as expression of
VLDLr (Fig. 4C). Moreover, overexpression of VLDLr in the condi-
tion of HIF-1a inhibition also induced ER stress and apoptosis
under hypoxia (Supplementary Fig. 1). In addition, hypoxia also
induces HIF-2a expression. However HIF-2a siRNA showed no
effect on VLDLr expression (Supplementary Fig. 2A and B). Taken
these ﬁndings together, hypoxia-induced enhancement in VLDLr
expression might depend on HIF-1a.
To further study the essential role of HIF-1a in the regulation of
VLDLr expression, reporter gene assays was carried out by coupling
the vldlr promoter to the luciferase gene. The data showed that
Fig. 4. Hypoxia induces expression of VLDLr through HIF-1a-dependent manner. (A) HUVECs were transfected with non-targeting control siRNA (siNT) or HIF-1a siRNA
(siHIF-1a), and after 48 h, cells were treated with normoxia or hypoxia for 8 h. (B) HUVECs were pretreated with DMSO or the HIF-1a stabilizer DMOG (1 mmol/L) for 30 min
prior to normoxia or hypoxia incubation for 8 h. (C) HUVECs were treated with CoCl2 (150 lM) for 12 or 24 h. The protein levels of VLDLr, HIF-1a, and b-actin were detected
by immunoblot analysis using indicated antibodies. A representative blot (top) was shown (n = 4). (D) HUVECs were transfected with luciferase constructs containing
fragments of vldlr promoter, and cells were cotransfected with siRNA against HIF-1a and then cultured in normoxia or hypoxia for 8 h, or cells were pretreated with DMSO or
DMOG (1 mmol/L) for 30 min prior to 8 h normoxia or hypoxia incubation, or cells were treated with CoCl2 (150 lM) for 12 or 24 h. Luciferase activity was measured using
Dual-luciferase Reporter Assay System (n = 6, means ± SE). ⁄P < 0.05 vs. hypoxia siNT cells; #P < 0.05 vs. hypoxia DMSO cells; &P < 0.05 vs. parallel normoxia cells. (E)
Luciferase activity of cells transfected with luciferase constructs containing fragments of vldlr promoter (pGL3vldlr) or the mutant promoter (pGL3vldlrHREmut) and
incubated in normoxia or hypoxia for 8 h (n = 6, means ± SE). ⁄P < 0.05 vs. normoxia pGL3vldlr cells; #P < 0.05 vs. hypoxia pGL3vldlr cells.
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increased the inﬂuence of hypoxia on the promotion of luciferase
activity, respectively (Fig. 4D). Furthermore, HIF-2a siRNA dis-
played no effect on the luciferase activity (Supplementary
Fig. 1C). These results suggested the importance of HIF-1a in thepromoter activity of vldlr. In silico analysis indicated the presence
of a potential HRE between 161 and 158 bp. Mutation of this
site completely inhibited the luciferase activity induced by hypoxia
(Fig. 4E). Collectively, we determined that HIF-1a is crucial for the
HRE activity in the vldlr promoter.
Fig. 5. VLDLr is essential for Hypoxia-triggered ER stress. HUVECs were transfected with non-targeting control siRNA or VLDLr siRNA, or HUVECs were transfected with
adenovirus vector (Ad-control) or VLDLr (Ad-VLDLr), and after 48 h, cells were incubated in normoxia or hypoxia for 8 h. (A) The relative mRNA levels of GRP78 and CHOP
were detected by q-PT-PCR (n = 6, means ± SE). ⁄P < 0.05 vs. hypoxia siNT cells; #P < 0.05 vs. hypoxia Ad-control cells. (B and C) The protein levels of GRP78, CHOP, p-PERK,
PERK, and b-actin were detected by immunoblot analysis using indicated antibodies. A representative blot (top) was shown (n = 4). Quantitative analysis of GRP78, CHOP, and
p-PERK (bottom) was expressed as fold increase above control group (n = 4, means ± SE). ⁄P < 0.05 vs. parallel normoxia control cells; #P < 0.05 vs. parallel hypoxia control
cells.
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We examined whether hypoxia-induced VLDLr expression
might involved in promoting endothelial ER stress. Compared with
cells transfected with non-target in siRNA, knockdown of VLDLr by
siRNA abolished increased expression levels of GRP78 and CHOP
(Fig. 5A and B). Instead, overexpression of VLDLr exacerbated
GRP78 and CHOP expression under hypoxia condition (Fig. 5A
and C). In addition, we showed that hypoxia-induced increases in
phosphorylation of PERK were markedly inhibited or promoted
in VLDLr-silenced or VLDLr-overexpressed cells, respectively
(Fig. 5). These ﬁndings thus indicated the essentiality of VLDLr
for hypoxia-triggered endothelial ER stress.3.6. VLDLr mediates hypoxia-induced endothelial apoptosis
To determine whether VLDLr affect hypoxia-induced endothe-
lial apoptosis, the expression levels of antiapoptotic Bcl-2, proa-
poptotic Bax, and activation of caspases was examined by
immunoblot in VLDLr-differently-expressed or VLDLr-overexpres-
sed cells. Knockdown or overexpression of VLDLr signiﬁcantly
abolished or exacerbated cleaved levels of caspase-3, caspase-9,
and caspase-4, respectively (Fig. 6A and B). However no obvious
difference was detected in cleaved caspase-8 (Fig. 6A and B). In
addition, the antiapoptotic Bcl-2 was inhibited by hypoxia, and
the inhibited effect was largely attenuated or promoted by trans-
fection of cells with VLDLr siRNA or VLDLr expression adenovirus
Fig. 6. VLDLr is essential for Hypoxia-induced apoptosis. HUVECs were transfected with non-targeting control siRNA or VLDLr siRNA, or HUVECs were transfected with Ad-
control or Ad-VLDLr, and after 48 h, cells were incubated in normoxia or hypoxia for 12 h. (A and B) The protein levels of cleaved caspase-3, cleaved caspase-9, cleaved
caspase-8, cleaved caspase-4, Bcl-2, Bax, and b-actin were detected by immunoblot analysis using indicated antibodies. A representative blot (left) was shown (n = 4).
Quantitative analysis of cleaved caspase-3, cleaved caspase-9, cleaved caspase-8, cleaved caspase-4, Bcl-2, and Bax (right) was expressed as fold increase above control group
(n = 4, means ± SE). ⁄P < 0.05 vs. parallel normoxia control cells; #P < 0.05 vs. parallel hypoxia control cells. (C) The cell apoptosis was measured by ﬂow cytometry analysis
and quantitative analysis of apoptotic cells was shown (n = 4, means ± SE). The values represent the mean percentages of apoptotic cells in different groups. ⁄P < 0.05 vs.
hypoxia siNT cells; #P < 0.05 vs. hypoxia Ad-control cells.
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signiﬁcant changes in the expression of proapoptotic Bax between
different expression levels of VLDLr (Fig. 6A and B). Furthermore,
ﬂow cytometry analysis showed that cells knockout or overexpres-sion of VLDLr presented a lower or elevated apoptotic level com-
pared with parallel VLDLr normally expressed cells (Fig. 6C).
Taken together, these results suggested a causal correlation
between VLDLr and endothelial apoptosis in hypoxia condition.
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In the current study, we demonstrated for the ﬁrst time that
hypoxia induced VLDLr expression which mediated the generation
of endothelial ER stress and apoptosis. The induction of VLDLr
expression by hypoxia was mediated by the interaction between
HIF-1a and HRE in the vldlr promoter. Thus, our ﬁndings present
novel molecular mechanisms that could contribute to the elucida-
tion of endothelial ER stress and apoptosis under hypoxia
condition.
The vascular endothelium maintains vascular homeostasis
through its important functions such as regulation of blood pres-
sure and coagulation, involvement of inﬂammatory processes,
and mediation of atherosclerotic lesions and stroke. The endoplas-
mic reticulum (ER) is a highly dynamic organelle existed in all
eukaryotic cells [13]. It plays a crucial roles in the folding of mem-
brane and secretory proteins, lipid biosynthesis, and calcium
homeostasis. The disturbed ER homeostasis results in accumula-
tion of misfolded or unfolded proteins in the ER, thus directing to
the activation of a special cellular process called UPR, which often-
times represents the event of ER stress [14]. Compelling evidences
indicated the importance of UPR and ER stress in the vascular com-
plications [15]. Damage of endothelial cells can be due to not only
oxidative stress, but also condition of ER stress [16]. Endothelial
cells are always predisposed to ER stress, since they were exposed
to multi-factor and multi-event status in blood, and possesses a
high volume of protein synthesis [17]. In our results, hypoxia trig-
gered endothelial ER stress manifested by elevated mRNA and pro-
tein levels of GRP78 and CHOP and increase of phosphorylated
PERK (Fig. 1), a ﬁnding that is in concert with some previous stud-
ies [18,19]. Primarily, the goal of UPR is to alleviate ER stress and
maintain cell survival. If ER stress lasted much longer or too severe,
signaling switches from pro-survival to pro-death, thus triggering
ER stress-induced apoptosis [20,21]. As a counterpart, endothelial
apoptosis after hypoxia was also detected, and death receptor-ini-
tiated (cleaved caspase-8), mitochondrial-dependent (cleaved cas-
pase-9, Bax, and Bcl-2), and ER stress-induced (cleaved caspase-4)
apoptosis pathways were triggered (Fig. 2).
VLDLr is found in most tissues of the body, with particularly
high expression in fatty acid tissues due to their high level of
VLDLr’s primary ligand, triglycerides. Endothelial cells express
low amount of VLDLr physiologically [22,23]. Previous studies indi-
cated that hypoxia promoted VLDLr mRNA expression in human
monocytes and Müller cells [24,25]. In concert with these ﬁndings,
we provided evidence that hypoxic stress induced VLDLr expres-
sion in endothelial cells (Fig. 3). We also showed that HIF-1a was
important for the hypoxia-induced VLDLr expression in endothelial
cells. Silencing of HIF-1a expression or stabilization of HIF-1a sig-
niﬁcantly inhibited or enhanced VLDLr expression, respectively
(Fig. 4A and B). CoCl2, a chemical inducer of HIF-1a, enhanced
expression of VLDLr (Fig. 4C). Moreover, using reporter gene assay,
we found a crucial role of HIF-1a in triggering vldlr promoter activ-
ity by its interaction with HRE in the promoter (Fig. 4D and E). Thus
we concluded that hypoxia-induced VLDLr expression was medi-
ated by binding of HIF-1a to HRE in the vldlr promoter.
As a peripheral remnant lipoprotein receiver, VLDLr is generally
linked to the lipid metabolism. More recently, the possibility of its
biological function extended to include signal transduction, cellu-
lar proliferation, and tumor pathogenesis [4]. With respect to
endothelial cells, there were some interesting ﬁndings. VLDLr, as
a novel endothelial receptor for ﬁbrin, promoted ﬁbrin-dependent
transmigration of leukocyte and thereby the subsequent inﬂam-
mation [7]. The suppression of endothelial cell proliferation by tis-
sue factor pathway inhibitor was mediated by VLDLr [26]. Loss of
VLDLr activated retinal vascular endothelial cells and promotedangiogenesis [6]. Further, it was reported that VLDLr was essential
for the inhibition of microvascular endothelial cell division [8].
Therefore, all these evidences proposed an important action of
VLDLr on regulation of endothelial biology. Our results provided
a causal relationship between VLDLr and endothelial ER stress, a
ﬁnding manifested by the responsiveness that the expression of
GRP78, CHOP, and phosphorylated PERK was affected by differen-
tially expressed VLDLr (Fig. 5). Furthermore, VLDLr was also an
active mediator within endothelial apoptosis. Knockdown or over-
expression of VLDLr inhibited or aggravated apoptosis induced by
hypoxia for 12 h (Fig. 6). Interestingly, although VLDLr inﬂuenced
hypoxia-mediated activation of caspase-3, caspase-9, and cas-
pase-4 and downregulation of Bcl-2, there were no signiﬁcant
alterations with respect to Bax and cleaved caspase-8 (Fig. 6A
and B). Thus, it seemed that VLDLr mediated endothelial apoptosis
special somehow. However, in our results, VLDLr did not affect
apoptosis signiﬁcantly under hypoxia for 24 h (data not shown).
It was shown that VLDLr expression was elevated at early stage
of hypoxia, and after 12 h of hypoxia it declined (Fig. 3). Thus,
we speculated that VLDLr was responsible for the apoptosis in
the early stage of hypoxia. Due to the decline of VLDLr expression,
the apoptosis was not mediated by VLDLr in the late stage of
hypoxia. Of course, there may be negative mediator involved in
the modulation of VLDLr expression beyond the positive regulator
of HIF-1a.
In conclusion, our study provided evidence, for the ﬁrst time,
that hypoxia triggers endothelial ER stress and apoptosis through
induction of VLDLr expression which involves the enhanced vldlr
promoter activity by HIF-1a interaction with HRE in the promoter.
Elucidation of the molecular mechanisms by which hypoxia
induces endothelial ER stress and apoptosis may have signiﬁcance
for therapy to reduce vascular ischemic injury.
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